These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22209148)

  • 1. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
    Gondi V; Hermann BP; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e487-93. PubMed ID: 22209148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
    Gondi V; Hermann BP; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):348-54. PubMed ID: 23312272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
    Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
    Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
    Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
    Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
    Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
    BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment.
    Kim KS; Wee CW; Seok JY; Hong JW; Chung JB; Eom KY; Kim JS; Kim CY; Park YH; Kim YJ; Kim IA
    Radiat Oncol; 2018 Feb; 13(1):29. PubMed ID: 29463267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
    Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
    Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study.
    Acharya S; Wu S; Ashford JM; Tinkle CL; Lucas JT; Qaddoumi I; Gajjar A; Krasin MJ; Conklin HM; Merchant TE
    Neuro Oncol; 2019 Sep; 21(9):1175-1183. PubMed ID: 30977510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors.
    Goda JS; Dutta D; Krishna U; Goswami S; Kothavade V; Kannan S; Maitre M; Bano N; Gupta T; Jalali R
    Neuro Oncol; 2020 Nov; 22(11):1677-1685. PubMed ID: 32227185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Radiation-Induced Hippocampal Vascular Injury Surrogate Marker Predicts Late Neurocognitive Dysfunction.
    Farjam R; Pramanik P; Aryal MP; Srinivasan A; Chapman CH; Tsien CI; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):908-15. PubMed ID: 26530761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis.
    Daniela Falco M; Giancaterino S; D'Andrea M; Gimenez De Lorenzo R; Trignani M; Caravatta L; Di Carlo C; Di Biase S; Allajbej A; Genovesi D
    J Appl Clin Med Phys; 2018 Jan; 19(1):86-93. PubMed ID: 29125239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
    Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
    J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric Analysis.
    Nguyen TK; Sahgal A; Detsky J; Soliman H; Myrehaug S; Tseng CL; Husain ZA; Carty A; Das S; Yang V; Lee Y; Sarfehnia A; Chugh BP; Yeboah C; Ruschin M
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):394-399. PubMed ID: 31283978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-sparing methods for IMRT of head and neck cancer.
    Dunlop A; Welsh L; McQuaid D; Dean J; Gulliford S; Hansen V; Bhide S; Nutting C; Harrington K; Newbold K
    PLoS One; 2015; 10(3):e0120141. PubMed ID: 25781636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance.
    Shrieve DC; Hazard L; Boucher K; Jensen RL
    J Neurosurg; 2004 Nov; 101 Suppl 3():390-5. PubMed ID: 15537194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal-sparing radiotherapy and neurocognitive impairment: A systematic literature review.
    Giuseppe ZR; Silvia C; Eleonora F; Gabriella M; Marica F; Silvia C; Mario B; Francesco D; Savino C; Milly B; Frezza GP; Maurizio Z; Morganti AG
    J Cancer Res Ther; 2020; 16(6):1215-1222. PubMed ID: 33342776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.
    Prokic V; Wiedenmann N; Fels F; Schmucker M; Nieder C; Grosu AL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):264-70. PubMed ID: 22516808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.
    Ma TM; Grimm J; McIntyre R; Anderson-Keightly H; Kleinberg LR; Hales RK; Moore J; Vannorsdall T; Redmond KJ
    Radiother Oncol; 2017 Nov; 125(2):234-240. PubMed ID: 29128167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1-10 Brain Metastases.
    Whitfield GA; Bulbeck H; Clifton-Hadley L; Edwards D; Jefferies S; Jenkinson MD; Griffin M; Handley J; Megias D; Sanghera P; Shaffer R; Short S; Wilson W
    Clin Oncol (R Coll Radiol); 2024 Nov; 36(11):681-689. PubMed ID: 39030085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.